UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Newsroom

    Spotlight Story

    UCB Dedicates Site for New U.S. Biologics Manufacturing Campus in Georgia

    Read more

    Press Releases

    UCB Dedicates Site for New U.S. Biologics Manufacturing Campus in Georgia

    Read More

    UCB data presented at 2026 AANEM Annual Meeting and MGFA Scientific Session underscore leadership…

    Read More

    UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA® (certolizumab pegol) in pregnant…

    Read More

    UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S.…

    Read More

    Axios Names UCB a Winner of the Metro Atlanta Top Workplaces 2026 Award

    Read More

    Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients…

    Read More

    UCB Stories

    Inside a PowerHouSe: Conversations, Connection & Learning at the 2026 UCB HS Summit

    Read More

    UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI®…

    Read More

    Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps

    Read More

    Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis

    Read More

    UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States

    Read More

    UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association…

    Read More

    For More Information